Integra LifeSciences Holdings Corp buy melinda
Start price
29.08.18
/
50%
€53.24
Target price
06.09.18
€55.92
Performance (%)
5.47%
End price
06.09.18
€56.15
Summary
This prediction ended on 06.09.18 with a price of €56.15. The BUY prediction by melinda finished with a performance of 5.47%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Integra LifeSciences Holdings Corp | 0.000% | 0.000% | -53.266% | -69.756% |
iShares Core DAX® | 1.560% | 2.566% | 18.261% | 16.927% |
iShares Nasdaq 100 | 0.517% | 1.894% | 25.521% | 35.441% |
iShares Nikkei 225® | 1.730% | 5.631% | 18.569% | 13.063% |
iShares S&P 500 | 1.482% | 1.594% | 24.989% | 38.339% |
Comments by melinda for this prediction
In the thread Integra LifeSciences Holdings Corp diskutieren
SecteurEquipement, fournitures et distribution médicale Agenda 06/09 | 14:35 Présentation
Develops, manufactures and markets medical devices, implants and biomaterials
Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment.
It operates through the Codman Specialty Surgical and Orthopedics and Tissue Technologies segments.
The Codman Specialty Surgical segment includes neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices.
The Orthopedics and Tissue Technologies segment comprises offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair.
The company was founded by Richard E. Caruso in 1989 and is headquartered in Plainsboro, NJ.
Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment.
It operates through the Codman Specialty Surgical and Orthopedics and Tissue Technologies segments.
The Codman Specialty Surgical segment includes neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices.
The Orthopedics and Tissue Technologies segment comprises offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair.
The company was founded by Richard E. Caruso in 1989 and is headquartered in Plainsboro, NJ.
Nombre d'employés : 4 400 personnes.
(Zielkurs erreicht)
Stopped prediction by melinda for Integra LifeSciences Holdings Corp
Integra LifeSciences Holdings Corp
Start price
Target price
Perf. (%)
€44.40
26.10.22
26.10.22
€48.00
26.10.23
26.10.23
-24.77%
26.10.23
26.10.23
Integra LifeSciences Holdings Corp
Start price
Target price
Perf. (%)
€45.33
28.09.17
28.09.17
€49.61
05.02.18
05.02.18
5.07%
05.02.18
05.02.18
Integra LifeSciences Holdings Corp
Start price
Target price
Perf. (%)
€48.26
07.07.17
07.07.17
€49.16
12.07.17
12.07.17
1.87%
12.07.17
12.07.17